Cirsiliol alleviates experimental inflammatory bowel disease via restoration of intestinal barrier integrity and inhibition of NF-κB and MAPK pathways
Sign Up to like & getrecommendations! Published in 2025 at "Scientific Reports"
DOI: 10.1038/s41598-025-09896-x
Abstract: Inflammatory bowel disease (IBD) involves chronic gut inflammation and barrier damage. While natural flavonoids show promise for IBD treatment, cirsiliol’s effects were unknown. This study examined cirsiliol’s therapeutic potential in mice with DNBS-induced colitis and… read more here.
Keywords: cirsiliol; disease; barrier; inflammatory bowel ... See more keywords